|Bid||0.00 x 1000|
|Ask||99.94 x 2200|
|Day's Range||54.55 - 55.37|
|52 Week Range||27.79 - 57.55|
|PE Ratio (TTM)||45.98|
|Earnings Date||Jul 31, 2018 - Aug 6, 2018|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||58.11|
The content of this article will benefit those of you who are starting to educate yourself about investing in the stock market and want to begin learning the link betweenRead More...
Globus Medical (GMED) has missed three consensus revenue estimates and one consensus EPS estimate in the last 20 quarters. It has a dividend yield of 0% compared to the sector and the S&P 500 at 0.9% and 2.3%, respectively. What contributed to GMED’s valuations?
Biotech stocks are also capitalizing on AI’s potential to deliver revolutionary drugs and speed up drug discovery. “I believe that AI is a sleeping giant for healthcare in general,” Eric Horvitz, director of Microsoft Research Labs, said earlier this year.
Globus Medical, Inc. (GMED), a leading musculoskeletal solutions company, today announced the launch of the CREO® Fenestrated Screw System used in the treatment of patients with advanced stage tumors of the thoracolumbar spine. CREO® fenestrated screws, when augmented with the company’s FORTRESS™ radiopaque bone cement, are designed to restore the structural integrity of the spine at vertebral levels affected by metastatic bone disease.
Cantor Fitzgerald is starting coverage on biotech companies in the spinal segment, a market that the investment house thinks has a $9-billion global market opportunity. Globus Medical Inc (NYSE:GMED) earned an “Overweight” rating from Cantor Fitzgerald. GMED stock has a market cap of $5.41 billion and is valued at 10.6 times its book value per share.
WallStEquities.com monitors four Medical Appliances and Equipment stocks, namely: Globus Medical Inc. (NYSE: GMED), Inspire Medical Systems Inc. (NYSE: INSP), InspireMD Inc. (NYSE AMER: NSPR), and LivaNova PLC (NASDAQ: LIVN). Audubon, Pennsylvania headquartered Globus Medical Inc.'s shares recorded a trading volume of 636,640 shares last Friday.
Spine stocks were steadied with supportive coverage from the Street this week. The Ratings Cantor Fitzgerald analysts Craig Bijou and Jordan Abrams initiated coverage on: Globus Medical Inc (NYSE: GMED ...
AUDUBON, Pa., May 21, 2018-- Globus Medical, Inc., a leading musculoskeletal solutions company, today announced the appointment of Daniel Gregoris to Vice President of Sales for the company’ s emerging ...
When you think of artificial intelligence (AI), you might not immediately think of the healthcare sector. Here we take a closer look at three intriguing stocks using AI to forge new advances in treating and tackling disease. To pinpoint these three stocks, we used TipRanks' data to scan for 'Strong Buy' stocks in the healthcare sector.
Globus Medical, Inc. (GMED), a leading musculoskeletal solutions company, today announced the results of the study “Clinical and radiographic analysis of expandable versus static lateral lumbar interbody fusion devices with two-year follow-up” published in the Journal of Spine Surgery, supporting benefits of Globus’ expandable lateral spacers. The study co-authored by Joseph O’Brien, MD, orthopedic surgeon at Washington Spine and Scoliosis Institute and Dr. Richard Frisch, orthopedic surgeon at Southeastern Spine Institute, compared clinical and radiographic outcomes of fifty-six patients who underwent minimally invasive lateral lumber interbody fusion (LLIF) for symptomatic degenerative disc disease. Radiographic evidence confirmed solid fusion was achieved in 100% of levels treated in both groups, however, significant differences in the rate of implant subsidence were observed.
Globus Medical, Inc. (GMED), a leading musculoskeletal solutions company, announced today it is sponsoring the Society of Lateral Access Surgery’s (SOLAS®) newly developed Partnership Program as that organization’s first corporate Alliance Partner. SOLAS® is a non-profit organization that strives to shape the future of lateral access spine surgery through collaboration among members, exchange of ideas, and the promotion of new techniques that benefit patients, physicians and hospitals. This sponsorship demonstrates Globus Medical’s commitment to supporting key educational and research initiatives important to advancing lateral access surgery. “Globus Medical recognizes that SOLAS® is the largest surgeon organization focused primarily on advancing lateral access surgery through peer-to-peer interaction and clinical research”, said Andrew Iott, Senior Vice President Global Product Development.
The new ExcelsiusGPS robotics and navigation system generates big sales growth for the medical-device company in the first quarter.
The Audubon, Pennsylvania-based company said it had net income of 39 cents per share. Earnings, adjusted for one-time gains and costs, were 41 cents per share. The results topped Wall Street expectations. ...
AUDUBON, Pa., May 02, 2018-- Globus Medical, Inc., a leading musculoskeletal solutions company, today announced its financial results for the first quarter ended March 31, 2018.. Worldwide sales were $174.4 ...
Along with Abiomed and Inogen, spinal implant manufacturer Globus Medical is among five top medical stocks with a 99 Composite Rating.
NEW YORK, April 20, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of ...
AUDUBON, Penn., April 17, 2018-- Globus Medical, Inc., a leading musculoskeletal solutions company, will announce its financial results for the first quarter ended March 31, 2018 after the market close ...
Globus Medical Inc (NYSE: GMED ) is up 64 percent year-over-year , but it may be exhausting its potential . The Rating BTIG analyst Ryan Zimmerman downgraded Globus Medical to Neutral. The Thesis Globus ...
Short interest is low for GMED with fewer than 5% of shares on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. The net inflows of $130 million over the last one-month into ETFs that hold GMED are among the lowest of the last year and appear to be slowing.
AUDUBON, Pa., April 05, 2018-- Globus Medical, Inc., a leading musculoskeletal solutions company, today announced the launch of two innovative lateral expandable interbody spacers with integrated screw ...
Stock Monitor: EDAP TMS Post Earnings Reporting LONDON, UK / ACCESSWIRE / April 04, 2018 / Active-Investors.com has just released a free earnings report on Globus Medical, Inc. (NYSE: GMED ) ("Globus"). ...
Globus Medical Inc. is making a big push in the orthopedic trauma market. The Audobon, Pa., manufacturer of implants and other devices used in spinal surgery, is displaying its growing portfolio of trauma products at this week's American Association of Orthopaedic Surgeons’ annual meeting in New Orleans. “We feel we can capitalize on our strengths of innovation and speed to market to bring game changing technology in the trauma market,” said Barclay Davis, vice president for orthopedic trauma at Globus.